Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment

NCT01620489 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

279

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: liraglutide
DRUG: placebo

Sponsor

Novo Nordisk A/S